GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,059 | 780 | 2,570 | 1,290 | 422 |
| Marketable Securities | N/A | 0 | 0 | 1,290 | 420 |
| Receivables | 502 | 1,070 | 990 | 2,010 | 860 |
| Inventories | 1,271 | 1,320 | 1,570 | 3,650 | 1,180 |
| Other current assets | 0 | 50 | 270 | -3,040 | -822 |
| TOTAL | $3,913 | $3,220 | $5,400 | $5,200 | $2,060 |
| Non-Current Assets | |||||
| PPE Net | 651 | 800 | 2,810 | 3,968 | 1,327 |
| Intangibles | 1,007 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 54 | 1,140 | 2,950 | 3,390 | 4,600 |
| TOTAL | $1,712 | $1,940 | $5,760 | $7,358 | $5,927 |
| Total Assets | $5,625 | $5,180 | $11,160 | $12,570 | $7,990 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 99 | 90 | 110 | 90 | 70 |
| Accounts payable and accrued liabilities | 628 | 1,130 | 710 | 1,550 | 1,510 |
| Accrued Expenses | 341 | 390 | 700 | 1,180 | 650 |
| Other current liabilities | 174 | 0 | 120 | N/A | N/A |
| TOTAL | $1,402 | $2,300 | $2,370 | $4,250 | $3,470 |
| Non-Current Liabilities | |||||
| Long Term Debt | 150 | 190 | 1,610 | 1,570 | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 2 |
| TOTAL | $150 | $190 | $1,610 | $1,570 | $2 |
| Total Liabilities | $1,552 | $2,490 | $3,980 | $5,820 | $1,155 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 8 | 8 | 6 | 6,890 |
| Retained earnings | -54,386 | -49,750 | -45,300 | -38,170 | -33,020 |
| Other shareholders' equity | 2,494 | -328 | -278 | -246 | -50 |
| TOTAL | $4,073 | $2,680 | $7,180 | $6,750 | $4,520 |
| Total Liabilities And Equity | $5,625 | $5,170 | $11,160 | $12,570 | $5,675 |